Inflection Point Acquisition Corp VI
IPFXU · NASDAQ
About IPFXU
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Mar 27, 2026
- Sector
- N/A
- Industry
- N/A
IPFXU key statistics
- Market cap
- 342.39M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 183
- Volume
- 2.61K
- Open price
- $10.35
- High today
- $10.36
- Low today
- $10.35
- 52 Week high
- $11.90
- 52 Week low
- $10.03
Inflection Point Acquisition Corp VI (IPFXU) at a glance
As of Oct 29, 2026, Inflection Point Acquisition Corp VI (IPFXU) shares are priced at $10.36, giving the company a market cap of 342.39M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $10.35 and $10.36. The current price is 0.1% above the day's low and 0.0% below its high.
Volume so far is 2.61K shares, above the average of 183 shares a day.
Over the past year Inflection Point Acquisition Corp VI has ranged from $10.03 to $11.90, and now sits 18% of the way up that range.
IPFXU news
- Press releaseBusiness Wire
Most active stocks
Highest trading volume today
- GTVHGolden Triangle Ventures$0.0001−50.00%
- BURUNuburu$0.3717+115.98%
- RDARRaadr$0.0002+0.00%
- WFFWF Holding$1.50+13.21%
- INLFINLIF$0.265+47.22%
- EARIEntertainment Arts Research$0.0002+0.00%
- ADTADT$9.87+33.20%
- AITXArtificial Intelligence Technology Solutions$0.0008+77.78%
- GOOGLAlphabet$283.82−12.64%
- NVDGraniteShares ETF Trust$4.09+2.00%
- INTCIntel$92.07−3.62%
- TIPSTianrong Internet Products & Services$0.0015+7.14%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.98+0.10%
- LYCALycia Therapeutics$27.73+10.70%
- DAVIDAVION HEALTHCARE$2.69−18.24%
- TCXBTCGX Acquisition Corp. II$10.21−0.61%
- CTYCITY THERAPEUTICS$22.14+2.26%
- IAMIambic Therapeutics$14.28−3.38%
- AMROAmaero$5.78−1.37%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.21−0.20%
- TRXBTRex Bio$13.52−6.31%
- RTSNRetension Pharmaceuticals$11.83−9.63%
- PAXGUPine Tree Acquisition$10.02−0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.